SCHEMBL27679404

SCHEMBL27679404

COC(=O)CCCCCCCCCCCC(C)(C)CCC(=O)CCCC(=O)CCC(C)(C)CC(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
FFAR1 O14842 1/20 0.41
CPT2 P23786 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 3/20 0.39
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.35
KMT2A Q03164 2/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
EPHX2 P34913 1/20 0.32
CA12 O43570 2/20 0.32
CA14 Q9ULX7 2/20 0.32
GLA P06280 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10259053 0.91 FFAR1 (0.48) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL14350639 0.89 FFAR1 (0.45) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL3283791 0.89 TSHR (0.46) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL3283751 0.85 TSHR (0.46) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL14350771 0.84 TSHR (0.54) TSHRLMNAALDH1A1RECQLKMT2A
SCHEMBL14350638 0.82 TSHR (0.52) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL14350765 0.82 TSHR (0.52) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL3282766 0.82 TSHR (0.42) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL27659346 0.81 TSHR (0.44) TSHRFFAR1CPT2TDP1LMNA
SCHEMBL8742572 0.78 TSHR (0.34) TSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1962596-A Ketone compounds and compositions for cholesterol management and related uses ESPERION THERAPEUTICS INC (US) 2007-05-16 CN disclosed